Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

Toonaangevende leiders

Alle informatieOndernemingenMarktenEconomie & ForexgrondstoffenRenteToonaangevende leidersFinanciŽle professionalAgendaSectoren 
HomepaginaAl het nieuwsHet meest gelezen nieuwsBiografieŽn van de Leiders
Portrait de Geoffrey von Maltzahn
Leeftijd : 39
Vermogen : 46 019 075 USD
Belangrijkste bedrijven : Kaleido Biosciences, Inc.
Overzicht 
Geoffrey von Maltzahn founded 8 companies, notably: Seres Therapeutics, Inc., Kaleido Biosciences, Inc. and Axcella Health, Inc.

He holds the position of Chief Executive Officer & Director at Tessera Therapeutics, Inc. (which he founded), Chief Innovation Officer & Director at Indigo Ag, Inc. (which he founded in 2013) and General Partner at Flagship Pioneering.

He is also on the board of Kaleido Biosciences, Inc. (former Chief Executive Officer) and Generate Biomedicines, Inc. (former Co-Chief Executive Officer).

He previously was Chief Technology Officer of Seres Therapeutics, Inc. (he founded the company in 2010), Vice President-Discovery at Axcella Health, Inc. (he founded the company in 2008) and Vice President-Corporate Development of Essentient, Inc. (a subsidiary of Axcella Health, Inc.) and President, Chief Executive Officer & Director at Cobalt Biomedicine, Inc.

He received an undergraduate degree and a doctorate from Massachusetts Institute of Technology and a graduate degree from the University of California San Diego.


Posities en verantwoordelijkheden van Geoffrey von Maltzahn 
NaamTitel Van
Kaleido Biosciences, Inc.
(Biotechnologie & Medisch Onderzoek)
Director 2017
Indigo Ag, Inc. Chief Innovation Officer & Director -
Tessera Therapeutics, Inc. Chief Executive Officer & Director -
Generate Biomedicines, Inc. Director 2018
Flagship Pioneering General Partner -
Resonance Therapeutics Founder -


Belangnemingen van Geoffrey von Maltzahn 
NaamAandelen%Totale waarde
Sana Biotechnology, Inc. (SANA)
(Biotechnologie & Medisch Onderzoek)
1 830 6100,97%43 916 334 USD
Kaleido Biosciences, Inc. (KLDO)
(Biotechnologie & Medisch Onderzoek)
342 4660,80%2 102 741 USD


Geoffrey von MaltzahnPersoonlijk netwerk 
Meest gelezen nieuws 
15/09BRAD SMITH : Microsoft kondigt inkoop van eigen aandelen aan tot $60 mrd, verhoogt dividend
MR
13/09MARTIN SORRELL : Sorrell's S4 Capital verhoogt winstverwachting tot 40%
MR
14/09STEPHEN SCHERR : Goldman Sachs benoemt Coleman als nieuwe CFO, ter vervanging van Scherr
MR
15/09ILHAM KADRI : Activist Bluebell Capital wil ontslag CEO Solvay
AM
Meer nieuws


© 2021 People and Ownership :   
Geoffrey von Maltzahn Verbindingen